18 Apr 2024
07:30 CEST |
VALLOUREC |
Vallourec progresses its holistic balance sheet refinancing with successful pricing of its 2032 Senior Notes offering
|
60101030 Oil Equipment and Services |
Other financial transaction |
18 Apr 2024
07:30 CEST |
FORVIA |
FIRST-QUARTER 2024 SALES
|
40101025 Auto Parts |
Sales |
18 Apr 2024
07:30 CEST |
MAUREL ET PROM |
Maurel & Prom: Q1 2024 Activity
|
60101010 Oil: Crude Producers |
Sales |
18 Apr 2024
07:30 CEST |
VALLOUREC |
Vallourec progresse dans le refinancement global de son bilan et annonce le succès du placement de ses obligations senior à échéance 2032
|
60101030 Oil Equipment and Services |
Other financial transaction |
18 Apr 2024
07:30 CEST |
FORVIA |
CHIFFRE D’AFFAIRES DU PREMIER TRIMESTRE 2024
|
40101025 Auto Parts |
Sales |
18 Apr 2024
07:03 CEST |
EDENRED |
Edenred : Chiffre d\'affaires T1 2024
|
50205015 Transaction Processing Services |
Corporate life |
18 Apr 2024
07:03 CEST |
EDENRED |
Edenred : Q1 2024 revenue
|
50205015 Transaction Processing Services |
Corporate life |
18 Apr 2024
07:02 CEST |
SARTORIUS STEDIM BIOTECH |
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
07:02 CEST |
SARTORIUS STEDIM BIOTECH |
Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
07:00 CEST |
BIOPHYTIS |
Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
07:00 CEST |
BIOPHYTIS |
Biophytis annonce la création d\'un Conseil Scientifique pour son étude clinique de phase 2 OBA dans l\'obésité
|
20103010 Biotechnology |
Other subject |
17 Apr 2024
22:15 CEST |
NANOBIOTIX |
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
|
20103010 Biotechnology |
Meetings / events |
17 Apr 2024
22:15 CEST |
NANOBIOTIX |
NANOBIOTIX publiera ses résultats financiers et opérationnels de l'exercice 2023 le 24 avril 2024
|
20103010 Biotechnology |
Meetings / events |
17 Apr 2024
19:30 CEST |
CATERING INTERNATIONAL & SERVICES S.A. |
CIS : Signature d’un contrat majeur de 40 M$ sur 3 ans au Kazakhstan.
|
50205020 Professional Business Support Services |
Legal |
17 Apr 2024
19:30 CEST |
CATERING INTERNATIONAL & SERVICES S.A. |
CIS : Résultats annuels 2023. CA T1 2024 en forte croissance : +33% (à TCC).
|
50205020 Professional Business Support Services |
General meeting / Board Meeting |
17 Apr 2024
19:30 CEST |
CATERING INTERNATIONAL & SERVICES S.A. |
CIS : Major $40 million contract spanning three years signed in Kazakhstan.
|
50205020 Professional Business Support Services |
Legal |
17 Apr 2024
19:30 CEST |
CATERING INTERNATIONAL & SERVICES S.A. |
CIS : 2023 annual results. Strong growth in Q1 2024 revenue: up 33% (at CC).
|
50205020 Professional Business Support Services |
General meeting / Board Meeting |
17 Apr 2024
19:21 CEST |
COVIVIO |
Covivio - Descriptif du programme de rachat d’actions
|
35102030 Office REITs |
Other subject |
17 Apr 2024
19:21 CEST |
COVIVIO |
Covivio - Description of the share buy-back program
|
35102030 Office REITs |
Other subject |
17 Apr 2024
19:20 CEST |
COVIVIO |
Covivio General Meeting of 17 April 2024: approval of the scrip dividend option
|
35102030 Office REITs |
Legal |
17 Apr 2024
19:20 CEST |
COVIVIO |
Assemblée Générale Covivio du 17 avril 2024 : approbation de l’option de paiement du dividende en actions
|
35102030 Office REITs |
Legal |
17 Apr 2024
19:19 CEST |
ARKEMA |
ARKEMA RENFORCE SA GAMME DE SOLUTIONS POUR LES BATTERIES DE NOUVELLE GÉNÉRATION AVEC UNE PRISE DE PARTICIPATION MAJORITAIRE DANS PROIONIC
|
55201000 Chemicals: Diversified |
Other subject |
17 Apr 2024
19:19 CEST |
ARKEMA |
Arkema Strengthens Its Range of Solutions for Next-Generation Batteries With the Acquisition of a Majority Stake in Proionic
|
55201000 Chemicals: Diversified |
Other subject |
17 Apr 2024
18:46 CEST |
MARIE BRIZARD WINE AND SPIRITS |
Marie Brizard Wine & Spirits: 2023 full-year earnings
|
45101015 Distillers and Vintners |
Income |
17 Apr 2024
18:46 CEST |
MARIE BRIZARD WINE AND SPIRITS |
Marie Brizard Wine & Spirits: Résultats annuels 2023
|
45101015 Distillers and Vintners |
Income |
17 Apr 2024
18:39 CEST |
TELEPERFORMANCE |
Teleperformance SE : Assemblée Générale Mixte du 23 mai 2024
|
50205020 Professional Business Support Services |
General meeting / Board Meeting |
17 Apr 2024
18:39 CEST |
TELEPERFORMANCE |
Teleperformance SE: Combined Shareholders’ Meeting of May 23, 2024
|
50205020 Professional Business Support Services |
General meeting / Board Meeting |
17 Apr 2024
18:30 CEST |
AIR FRANCE -KLM |
Press release - Air France-KLM, Air France and KLM RCF extension
|
40501010 Airlines |
Other subject |
17 Apr 2024
18:30 CEST |
AIR FRANCE -KLM |
Communiqué de presse - extension de RCF Air France-KLM, Air France et KLM
|
40501010 Airlines |
Other subject |
17 Apr 2024
18:20 CEST |
CIBOX INTER A CTIV |
Point sur l'activité et le projet industriel Croissance de 67% au premier trimestre
|
10102030 Computer Hardware |
Legal |
17 Apr 2024
18:15 CEST |
EXAIL TECHNOLOGIES |
Information sur le programme SEA 1905 pour la marine australienne
|
50204000 Machinery: Industrial |
Legal |
17 Apr 2024
18:15 CEST |
EXAIL TECHNOLOGIES |
Information on the SEA-1905 program for the Australian navy
|
50204000 Machinery: Industrial |
Legal |
17 Apr 2024
18:05 CEST |
GETLINK SE |
Getlink SE: Information Relating to the Total Number of Shares and Voting Rights Which Form the Share Capital
|
50206020 Railroads |
Other subject |
17 Apr 2024
18:05 CEST |
GETLINK SE |
Getlink SE : Information relative au nombre total des droits de vote existants et d’actions composant le capital social
|
50206020 Railroads |
Other subject |
17 Apr 2024
18:04 CEST |
HOPSCOTCH GROUPE |
HOPSCOTCH GROUPE : Droits de vote et actions mars 2024
|
40301020 Media Agencies |
Share history |
17 Apr 2024
18:01 CEST |
SOCIETE GENERALE |
Societe Generale: Availability or consultation of the information relating to the combined General Meeting of Shareholders dated 22 May 2024
|
30101010 Banks |
General meeting / Board Meeting |
17 Apr 2024
18:01 CEST |
SOCIETE GENERALE |
Société Générale : Mise à disposition ou consultation des informations relatives à l’Assemblée Générale Mixte des actionnaires du 22 mai 2024
|
30101010 Banks |
General meeting / Board Meeting |
17 Apr 2024
18:00 CEST |
FLORENTAISE S.A. |
TERRASTIM : Greenchar® + Flomix, le cocktail booster par Florentaise pour le sol des villes
|
55201015 Fertilizers |
News contracts, New, Other subject |
17 Apr 2024
18:00 CEST |
EUROPLASMA |
EUROPLASMA: Fin des discussions exclusives en vue d’un rapprochement avec la société Adomos
|
65103035 Waste and Disposal Services |
Other subject |
17 Apr 2024
18:00 CEST |
IPSEN |
Ipsen publishes its 2023 Universal Registration Document
|
20103015 Pharmaceuticals |
Corporate life |
17 Apr 2024
18:00 CEST |
ONCODESIGN PRECISION MEDICINE |
Oncodesign Precision Medicine (OPM) obtient un financement public de 5,6 M€ pour son programme DEMOCRITE dédié au développement clinique d’OPM-101
|
20103010 Biotechnology |
Other subject |
17 Apr 2024
18:00 CEST |
GETLINK SE |
Getlink : Modalités de mise à disposition des informations relatives à l’Assemblée générale du 7 mai 2024
|
50206020 Railroads |
General meeting / Board Meeting |
17 Apr 2024
18:00 CEST |
ONCODESIGN PRECISION MEDICINE |
Oncodesign Precision Medicine (OPM) obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101
|
20103010 Biotechnology |
Other subject |
17 Apr 2024
18:00 CEST |
GETLINK SE |
Getlink: Access to Information Relating to the General Meeting to Be Held on May 7, 2024
|
50206020 Railroads |
General meeting / Board Meeting |
17 Apr 2024
18:00 CEST |
SPINEGUARD |
SpineGuard annonce ses résultats annuels 2023 et son chiffre d’affaires du 1er trimestre 2024
|
20102010 Medical Equipment |
Sales |
17 Apr 2024
18:00 CEST |
IPSEN |
Ipsen publie son Document d’enregistrement universel 2023
|
20103015 Pharmaceuticals |
Corporate life |
17 Apr 2024
18:00 CEST |
DRONE VOLT |
DRONE VOLT dépasse largement ses objectifs trimestriels en triplant sa marge brute à fin mars 2024
|
50201010 Aerospace |
Sales, Income |
17 Apr 2024
18:00 CEST |
LES HOTELS BAVEREZ |
Les Hôtels Baverez : Information Trimestrielle - 1er Trimestre 2024
|
40501025 Hotels and Motels |
- |
17 Apr 2024
18:00 CEST |
SPARTOO |
SPARTOO ANNONCE LA MISE A DISPOSITION DE SON RAPPORT FINANCIER ANNUEL 2023
|
40401020 Apparel Retailers |
Other subject |
17 Apr 2024
18:00 CEST |
JACQUET METALS |
JACQUET METALS SA: Statement in Compliance With the Article 223-16 of the General Regulation of the Financial Markets Authority (AMF - Autorité des Marchés Financiers)
|
55102010 Iron and Steel |
Other subject |